Logo-ps

 

Follower of ICMJE

Powered by:
Pharm Sci. 2025;31(3): 322-329. doi: 10.34172/PS.025.41013

Research Article

The Effects of Probiotic Supplementation on Level of Disability, Depressive Symptoms, and Cognitive Outcomes in Relapsing-Remitting Multiple Sclerosis Patients: A Randomized Double-Blind Placebo-Controlled Trial

Amirreza Naseri 1 ORCID, Sarvin Sanaie 2 ORCID, Sama Rahnemayan 2 ORCID, Reza Mosaddeghi-Heris 2 ORCID, Malihe Talebi 2, Mahnaz Talebi 2 * ORCID

Cited by CrossRef:

1- Navadeh Shahla H, Jahanshahlou F, Nourizadeh M, Ostad-Hassanzadeh B, Roshani S, Talebi M, Sanaie S, Naseri A. Dietary regimens and cognitive function in multiple sclerosis: a systematic review. Brain, Behavior, & Immunity - Health. 2026;56:101302 [Crossref]
2- Abbasi H, Ahmadi B, Sherafati N, Ansarian R, Pourebrahimian Leilabadi S, Hamzehzadeh S, Dehzadeh R, Talebi M, Sanaie S, Nikniaz L, Naseri A, Gurumallesh Prabu P. The Association Between Serum α‐Tocopherol and Pathogenesis of Multiple Sclerosis: A Systematic Review and Meta‐Analysis of Case‐Control Studies. BioMed Research International. 2026;2026(1) [Crossref]
3- Eghbal Y, Naseri A. Retracted evidence and emerging insights: an updated meta-analysis of probiotics supplementation on inflammatory and oxidative stress markers in multiple sclerosis. Multiple Sclerosis and Related Disorders. 2026;111:107264 [Crossref]

   Indexing & Abstracting: